Oscient Pharmaceuticals Corp. and a handful of affiliates have filed a patent-infringement suit in Maryland district court against Lupin Pharmaceuticals and its parent company Lupin Limited, based in India.
At issue is an Abbreviated New Drug Application, filed by Baltimore-based Lupin that Oscient claims infringes on its cholesterol-fighting drug Antara.
Details are Here
No comments:
Post a Comment